[{"Assets_0_FY_USD":773855000.0,"CIK":"1737287","CommonStockDividendsPerShareDeclared_4_FY_USD":0.0,"CommonStockSharesConverted_0_FY_shares":121482671.0,"CommonStockSharesOutstanding_0_FY_shares":121482671.0,"Country":"United States","EarningsPerShareBasic_1_FY_USD":-0.37,"EarningsPerShareBasic_4_FY_USD":-7.31,"Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-44653000.0,"NetIncomeLossConverted_1_FY_USD":-30509000.0,"NetIncomeLossConverted_4_FY_USD":-211505000.0,"OfficialName":"Allogene Therapeutics Inc. Common Stock","SP500":"nan","Sector":"Health Care","StockholdersEquity_0_FY_USD":703164000.0,"Ticker":"ALLO","filed":"20190308","footnote":"nan","form":"10-K","fp":"FY","fy":"2018.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20181231","qtrs":"0","uom":"USD"}]